Comparative analysis of continuous pericapsular nerve group block and supra-inguinal fascia iliaca compartment block for postoperative analgesia in total hip arthroplasty: a randomized controlled trial

髋关节置换术后镇痛中,连续性关节囊周围神经阻滞与髂筋膜上间隙阻滞的比较分析:一项随机对照试验

阅读:1

Abstract

BACKGROUND: Effective postoperative pain management is essential for recovery after total hip arthroplasty. While opioids are commonly used, their adverse effects necessitate alternative strategies. Peripheral nerve blocks are increasingly utilized, including the pericapsular nerve group block and the supra-inguinal fascia iliaca compartment block. However, comparative data on their efficacy remain limited. This randomized controlled trial evaluated the analgesic effectiveness of these two techniques. The primary outcome was postoperative pain scores at rest and with movement. Secondary outcomes included opioid consumption, the need for rescue analgesia, and hemodynamic stability. METHODS: Sixty patients undergoing total hip arthroplasty under general anesthesia were randomly assigned to receive either a pericapsular nerve group block or a supra-inguinal fascia iliaca compartment block. Standardized ultrasound-guided techniques were used with equal volumes of local anesthetic. Pain scores were assessed postoperatively using the Visual Analog Scale. Opioid consumption and rescue analgesia use were recorded for twenty-four hours. RESULTS: At 12 and 24 h postoperatively, median VAS scores at rest and during movement were significantly lower in the PENG group (≤ 2.0) compared to the SIFICB group (> 4.0) (P < 0.001). Opioid consumption in the first 24 h was significantly lower in the PENG group (11.1 ± 1.5 mg morphine equivalents) than in the SIFICB group (18.4 ± 2.5 mg; P < 0.001). Hemodynamic parameters were stable, with no significant complications. CONCLUSIONS: The pericapsular nerve group block provided superior analgesia and reduced opioid consumption compared to the supra-inguinal fascia iliaca compartment block. It should be considered a practical component of multimodal pain management for total hip arthroplasty. IRB NUMBER: Ethics Committee of Tekirdağ Namık Kemal University (2023.06.01.06). CLINICAL TRIAL REGISTRATION NUMBER: https://clinicaltrials.gov (NCT06806865).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。